Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Scalp micro-wounding helps promote hair growth in female pattern hair loss.

Repigmentation patterns in vitiligo depend on melanocyte source, lesion status, and therapy choice.

Minoxidil works faster, but ketoconazole is a safer alternative for female hair loss.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Gray-scale ultrasound effectively detects erectile tissue fibrosis in young men with erectile dysfunction after using finasteride.

Biotin supplements are not proven to improve hair or nails and may interfere with medical tests.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Fetal death was caused by umbilical cord stricture with hair growth in the Wharton jelly.

Tofacitinib may help treat severe hair loss, but more research is needed.

Scalp medical tattooing effectively camouflages bifid parietal whorls.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

Different autoantibody groups in pediatric SLE are linked to specific symptoms and disease outcomes.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Clascoterone cream could be used for other skin conditions affected by hormones.

Both 0.01% and 0.03% bimatoprost safely improve eyebrow fullness, with a patient preference for the 0.03% concentration.

Finasteride made hair thicker on the back of the head in men with hair loss.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Genetic factors affecting skin health and body weight may increase the risk of dermatophytosis.

Hair loss link to severe COVID-19 unclear.

SMAs improve patient satisfaction and may be cost-effective for female hair loss.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Mineral levels in hair don't significantly affect the severity of atopic dermatitis in children.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

HST and HST/F promote hair growth and may help treat alopecia.